Acute myelogenous leukemia in adolescents and young adults
The incidence of acute myelogenous leukemia (AML) increases progressively with age. Favorable genetic mutations are most prevalent in children, and unfavorable profiles increase proportionately in adolescents and young adults (AYA) and into later adulthood. Survival rates of AYA have improved over r...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
[September 2018]
|
| In: |
Pediatric blood & cancer
Year: 2018, Jahrgang: 65, Heft: 9 |
| ISSN: | 1545-5017 |
| DOI: | 10.1002/pbc.27089 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1002/pbc.27089 Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.27089 |
| Verfasserangaben: | Ursula Creutzig, Matthew A. Kutny, Ronald Barr, Richard F. Schlenk, Raul C. Ribeiro |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1668309203 | ||
| 003 | DE-627 | ||
| 005 | 20220816182154.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190702s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/pbc.27089 |2 doi | |
| 035 | |a (DE-627)1668309203 | ||
| 035 | |a (DE-599)KXP1668309203 | ||
| 035 | |a (OCoLC)1341231690 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Creutzig, Ursula |e VerfasserIn |0 (DE-588)1147990859 |0 (DE-627)1007479507 |0 (DE-576)496126873 |4 aut | |
| 245 | 1 | 0 | |a Acute myelogenous leukemia in adolescents and young adults |c Ursula Creutzig, Matthew A. Kutny, Ronald Barr, Richard F. Schlenk, Raul C. Ribeiro |
| 264 | 1 | |c [September 2018] | |
| 300 | |b Diagramme | ||
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 18 April 2018 | ||
| 500 | |a Gesehen am 02.07.2019 | ||
| 520 | |a The incidence of acute myelogenous leukemia (AML) increases progressively with age. Favorable genetic mutations are most prevalent in children, and unfavorable profiles increase proportionately in adolescents and young adults (AYA) and into later adulthood. Survival rates of AYA have improved over recent decades to 50-60%, but their accrual to clinical trials remains poor. In contrast to AYA with acute lymphoblastic leukemia, the prognostic benefit for AYA with AML enrolled in pediatric compared with adult trials is minor and only seen when different protocols are used. The distinctive needs of AYA, including intensive psychological services, call for their treatment within specialized centers that offer complex supportive care. | ||
| 650 | 4 | |a acute myelogenous leukemia (AML) | |
| 650 | 4 | |a adolescents and young adults (AYA) | |
| 650 | 4 | |a clinical trials | |
| 650 | 4 | |a prognosis | |
| 650 | 4 | |a survival | |
| 700 | 1 | |a Kutny, Matthew A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barr, Ronald |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schlenk, Richard Friedrich |d 1965- |e VerfasserIn |0 (DE-588)129025380 |0 (DE-627)387778004 |0 (DE-576)297454102 |4 aut | |
| 700 | 1 | |a Ribeiro, Raul C. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric blood & cancer |d New York, NY : Wiley, 2004 |g 65 (2018,9) Artikel-Nummer 27089, Seite 1-9, 9 Seiten |h Online-Ressource |w (DE-627)37682798X |w (DE-600)2130978-4 |w (DE-576)11281610X |x 1545-5017 |7 nnas |a Acute myelogenous leukemia in adolescents and young adults |
| 773 | 1 | 8 | |g volume:65 |g year:2018 |g number:9 |g extent:9 |a Acute myelogenous leukemia in adolescents and young adults |
| 856 | 4 | 0 | |u https://doi.org/10.1002/pbc.27089 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.27089 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190702 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 129025380 |a Schlenk, Richard Friedrich |m 129025380:Schlenk, Richard Friedrich |d 910000 |d 910100 |e 910000PS129025380 |e 910100PS129025380 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 999 | |a KXP-PPN1668309203 |e 3490481992 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"[September 2018]","dateIssuedKey":"2018"}],"relHost":[{"title":[{"title_sort":"Pediatric blood & cancer","title":"Pediatric blood & cancer"}],"id":{"zdb":["2130978-4"],"doi":["10.1002/(ISSN)1545-5017"],"eki":["37682798X"],"issn":["1545-5017"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"New York, NY","dateIssuedKey":"2004","dateIssuedDisp":"2004-","publisher":"Wiley"}],"recId":"37682798X","disp":"Acute myelogenous leukemia in adolescents and young adultsPediatric blood & cancer","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Pediatric blood and cancer"}],"language":["eng"],"part":{"extent":"9","issue":"9","text":"65 (2018,9) Artikel-Nummer 27089, Seite 1-9, 9 Seiten","year":"2018","volume":"65"},"note":["Gesehen am 13.05.14"],"pubHistory":["42.2004 -"]}],"id":{"eki":["1668309203"],"doi":["10.1002/pbc.27089"]},"physDesc":[{"extent":"9 S.","noteIll":"Diagramme"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Acute myelogenous leukemia in adolescents and young adults","title_sort":"Acute myelogenous leukemia in adolescents and young adults"}],"note":["First published: 18 April 2018","Gesehen am 02.07.2019"],"person":[{"display":"Creutzig, Ursula","given":"Ursula","role":"aut","family":"Creutzig"},{"role":"aut","family":"Kutny","given":"Matthew A.","display":"Kutny, Matthew A."},{"family":"Barr","role":"aut","given":"Ronald","display":"Barr, Ronald"},{"given":"Richard Friedrich","display":"Schlenk, Richard Friedrich","family":"Schlenk","role":"aut"},{"given":"Raul C.","display":"Ribeiro, Raul C.","role":"aut","family":"Ribeiro"}],"recId":"1668309203","language":["eng"],"name":{"displayForm":["Ursula Creutzig, Matthew A. Kutny, Ronald Barr, Richard F. Schlenk, Raul C. Ribeiro"]}} | ||
| SRT | |a CREUTZIGURACUTEMYELO2018 | ||